FR2920311B1 - Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation - Google Patents
Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparationInfo
- Publication number
- FR2920311B1 FR2920311B1 FR0757295A FR0757295A FR2920311B1 FR 2920311 B1 FR2920311 B1 FR 2920311B1 FR 0757295 A FR0757295 A FR 0757295A FR 0757295 A FR0757295 A FR 0757295A FR 2920311 B1 FR2920311 B1 FR 2920311B1
- Authority
- FR
- France
- Prior art keywords
- orodispersible
- dispersible
- excipient
- knowledge
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 title 1
- 239000008247 solid mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0757295A FR2920311B1 (fr) | 2007-08-31 | 2007-08-31 | Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation |
CA2697893A CA2697893A1 (fr) | 2007-08-31 | 2008-08-29 | Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation |
US12/201,078 US20090110725A1 (en) | 2007-08-31 | 2008-08-29 | Solid, orodispersible and/or dispersible composition, without an excipient of known effect and its process of preparation |
AU2008292085A AU2008292085A1 (en) | 2007-08-31 | 2008-08-29 | Solid, orodispersible and/or dispersible composition, without an excipient of known effect and method for preparing same |
PCT/EP2008/061420 WO2009027521A1 (fr) | 2007-08-31 | 2008-08-29 | Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation |
EP08787573A EP2185137A1 (fr) | 2007-08-31 | 2008-08-29 | Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation |
US13/169,836 US20110250272A1 (en) | 2007-08-31 | 2011-06-27 | Solid, orodispersible and/or dispersible composition, without an excipient of known effect and its process of preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0757295A FR2920311B1 (fr) | 2007-08-31 | 2007-08-31 | Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2920311A1 FR2920311A1 (fr) | 2009-03-06 |
FR2920311B1 true FR2920311B1 (fr) | 2010-06-18 |
Family
ID=39706821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0757295A Expired - Fee Related FR2920311B1 (fr) | 2007-08-31 | 2007-08-31 | Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation |
Country Status (6)
Country | Link |
---|---|
US (2) | US20090110725A1 (fr) |
EP (1) | EP2185137A1 (fr) |
AU (1) | AU2008292085A1 (fr) |
CA (1) | CA2697893A1 (fr) |
FR (1) | FR2920311B1 (fr) |
WO (1) | WO2009027521A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2468254A1 (fr) * | 2010-12-15 | 2012-06-27 | Hexal AG | Comprimé à désintégration orale doté d'un effet de masquage du goût |
CN103284969B (zh) * | 2013-07-01 | 2015-05-27 | 南京正宽医药科技有限公司 | 一种利培酮分散片及其制备方法 |
UA123098C2 (uk) | 2015-06-18 | 2021-02-17 | Естетра Спрл | Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент |
PE20231714A1 (es) | 2015-06-18 | 2023-10-23 | Estetra Sprl | Unidad de dosificacion orodispersable que contiene un componente estetrol |
KR102203229B1 (ko) * | 2016-01-08 | 2021-01-14 | 에리슨제약(주) | 용출률이 개선된 네비보롤을 포함하는 약학적 조성물 |
WO2017201071A1 (fr) * | 2016-05-16 | 2017-11-23 | Foster Howell | Polythérapie pour un dysfonctionnement sexuel chez l'homme |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2679451B1 (fr) * | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
US5298261A (en) * | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
FR2785538B1 (fr) * | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
US6296868B1 (en) * | 1998-11-19 | 2001-10-02 | Advanced Technology Pharmaceuticals Corporation | Chewable tablets containing mannitol and aspartame |
FR2834889B1 (fr) * | 2002-01-18 | 2004-04-02 | Roquette Freres | Forme pharmaceutique solide orodispersible |
-
2007
- 2007-08-31 FR FR0757295A patent/FR2920311B1/fr not_active Expired - Fee Related
-
2008
- 2008-08-29 CA CA2697893A patent/CA2697893A1/fr not_active Abandoned
- 2008-08-29 AU AU2008292085A patent/AU2008292085A1/en not_active Abandoned
- 2008-08-29 EP EP08787573A patent/EP2185137A1/fr not_active Withdrawn
- 2008-08-29 WO PCT/EP2008/061420 patent/WO2009027521A1/fr active Application Filing
- 2008-08-29 US US12/201,078 patent/US20090110725A1/en not_active Abandoned
-
2011
- 2011-06-27 US US13/169,836 patent/US20110250272A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2920311A1 (fr) | 2009-03-06 |
WO2009027521A1 (fr) | 2009-03-05 |
AU2008292085A1 (en) | 2009-03-05 |
CA2697893A1 (fr) | 2009-03-05 |
US20090110725A1 (en) | 2009-04-30 |
US20110250272A1 (en) | 2011-10-13 |
EP2185137A1 (fr) | 2010-05-19 |
AU2008292085A2 (en) | 2010-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2920311B1 (fr) | Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation | |
FR2911866B1 (fr) | Solide cristalise izm-1 et son procede de preparation. | |
HK1210137A1 (en) | Process for the preparation of 2,3,3,3-tetrafluoropropene 2333- | |
GB0715896D0 (en) | Microporous polymers, methods for the preparation thereof, and uses thereof | |
IL238438A0 (en) | 2,2,2-trifluoroacetophenones and a method for their preparation | |
DK3872058T3 (en) | Process for the preparation of 2,3,3,3 tetrahydrofluoropropene | |
HK1153728A1 (zh) | 製備 -四氟丙烯的方法 | |
ZA201007526B (en) | Process for the preparation of 2,3,3,3-tetrafluoropropene | |
BRPI0820843A2 (pt) | Sistema de monitoração de eletrocardiograma, e, método para operar o mesmo | |
FR2903992B1 (fr) | Composition de scintillateur, article et procede associe. | |
FR2945756B1 (fr) | Materiau solide nanocomposite a base d'hexa-et octacyanometallates, son procede de preparation et procede de fixation de polluants mineraux le mettant en oeuvre. | |
HK1201822A1 (en) | Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds 56--1h--2- | |
EP2367808A4 (fr) | g-LACTONES D'ACIDE 3-(6,6-ÉTHYLÈNE-17b-HYDROXY-3-OXO-17a-PRÉGNA-4-ÈNE-17a-YL) PROPIONIQUE PROGESTATIVES | |
FR2932486B1 (fr) | Procede de preparation d'un polyamideimide, polyamideimide et composition comprenant ce polyamideimide. | |
FR2897775B1 (fr) | Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations | |
IL207640A (en) | Manufacturing Method for 3,5 - Di-Converted 2, 4 6 - Tri-Iodophenols by Adding Iodine to Parallel Phenols | |
ZA201103259B (en) | Live,attentuated respiratory syncytial virus | |
FR2920775B1 (fr) | Nouveaux composes diaminophenothiazine, leur procede de preparation et leurs utilisations. | |
FR2939433B1 (fr) | Procede de preparation d'allophanate, allophanate et composition de faible viscosite comprenant l'allophanate | |
EP2220103A4 (fr) | Nouveaux sels de calcium de mangiférine, leur procédé de préparation et leur utilisation | |
FR2918979B1 (fr) | Solide cristallise im-16 et son procede de preparation | |
EP2156781A4 (fr) | Système endoscopique de type à capsule, et programme et procédé pour le système | |
FR2925047B1 (fr) | Procede de preparation de composes p-hydroxymandeliques eventuellement substitues et derives. | |
FR2925499B1 (fr) | Maltitol granule pour compression directe et son procede de preparation | |
FR2912400B1 (fr) | Materiau alveolaire hybride,procede pour sa preparation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20130430 |
|
RN | Application for restoration |
Effective date: 20130709 |
|
FC | Decision of inpi director general to approve request for restoration |
Effective date: 20140425 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |